Gilead Sciences, Inc. vs Western Digital Corp — how do they compare? Gilead Sciences, Inc. trades at $135.34 (market cap $168.35B), while Western Digital Corp trades at $449.64 (market cap $150.95B). The key difference: Gilead Sciences, Inc. and Western Digital Corp are close in size by market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| GILD | WDC | |
|---|---|---|
Market Cap | $168.35B | $150.95B |
Sector | Health | Technology |
52-Week High | $155.80 | $746.23 |
52-Week Low | $110.56 | $74.66 |
Enterprise Value | $191.42B | $150.42B |
Dividend Yield | 2.42% | 0.14% |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →